- Home
- SPNS vs AAPG Comparison
SPNS vs AAPG Comparison
Compare SPNS & AAPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPNS
- AAPG
- Stock Information
- Founded
- SPNS 1982
- AAPG 2009
- Country
- SPNS Israel
- AAPG China
- Employees
- SPNS N/A
- AAPG N/A
- Industry
- SPNS Computer Software: Prepackaged Software
- AAPG Biotechnology: Pharmaceutical Preparations
- Sector
- SPNS Technology
- AAPG Health Care
- Exchange
- SPNS Nasdaq
- AAPG Nasdaq
- Market Cap
- SPNS 1.5B
- AAPG 2.1B
- IPO Year
- SPNS 1992
- AAPG 2025
- Fundamental
- Price
- SPNS $27.90
- AAPG $24.25
- Analyst Decision
- SPNS Buy
- AAPG Buy
- Analyst Count
- SPNS 4
- AAPG 1
- Target Price
- SPNS $33.50
- AAPG N/A
- AVG Volume (30 Days)
- SPNS 183.2K
- AAPG 32.8K
- Earning Date
- SPNS 05-08-2025
- AAPG 05-20-2025
- Dividend Yield
- SPNS 3.36%
- AAPG N/A
- EPS Growth
- SPNS 11.11
- AAPG N/A
- EPS
- SPNS 1.30
- AAPG N/A
- Revenue
- SPNS $544,235,000.00
- AAPG $134,352,180.00
- Revenue This Year
- SPNS $4.49
- AAPG N/A
- Revenue Next Year
- SPNS $5.15
- AAPG $389.09
- P/E Ratio
- SPNS $22.35
- AAPG N/A
- Revenue Growth
- SPNS 3.84
- AAPG 341.77
- 52 Week Low
- SPNS $23.69
- AAPG $16.50
- 52 Week High
- SPNS $41.22
- AAPG $26.50
- Technical
- Relative Strength Index (RSI)
- SPNS 57.33
- AAPG N/A
- Support Level
- SPNS $28.10
- AAPG N/A
- Resistance Level
- SPNS $29.90
- AAPG N/A
- Average True Range (ATR)
- SPNS 0.76
- AAPG 0.00
- MACD
- SPNS 0.17
- AAPG 0.00
- Stochastic Oscillator
- SPNS 59.83
- AAPG 0.00
About SPNS Sapiens International Corporation N.V. (Cayman Islands)
Sapiens International Corp NV is a provider of software solutions for the insurance industry, with an emerging focus on the financial services sector. The company offers software, solutions, and professional services for property & casualty (P&C); reinsurance; life, pension & annuity (L&A); workers' compensation (WC); medical professional liability (MPL); financial & compliance (F&C); and decision modeling for both insurance and financial markets. The group also provides services for project delivery and implementation services, for its Software Solutions portfolio. Geographically, it operates in the region of North America, Rest of the World, and Europe. It generates revenue from Europe.
About AAPG Ascentage Pharma Group International American Depository Shares
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.